Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain

Leslie, 2001, Autoantibodies as predictor of disease, J Clin Investig, 108, 1417, 10.1172/JCI14452 Bizarro, 2007, Autoimmune as predictor of disease: the clinical and experimental evidence, Autoimmun Rev, 6, 325, 10.1016/j.autrev.2007.01.006 Solomon, 2002, Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing, Arthritis Rheum, 47, 434, 10.1002/art.10561 Routsias, 2010, B-cell epitopes of the intracellular autoantigens Ro/SSA and anti-La/SSB: tools to study the regulation of the autoimmune response, J Autoimmun, 35, 256, 10.1016/j.jaut.2010.06.016 Abeles, 2013, The clinical utility of a positive antinuclear antibody test result, Am J Med, 126, 342, 10.1016/j.amjmed.2012.09.014 Defendenti, 2011, Clinical and laboratory aspects of Ro/SSA-52 autoantibodies, Autoimmun Rev, 10, 150, 10.1016/j.autrev.2010.09.005 Hernandez-Molina, 2011, The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome, Autoimmun Rev, 10, 123, 10.1016/j.autrev.2010.09.001 Ramos-Casals, 2010, Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria, Clin Rev Allergy Immunol, 38, 178, 10.1007/s12016-009-8152-z Ramos-Casals, 2008, Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients, Medicine (Baltim), 87, 210, 10.1097/MD.0b013e318181e6af Meyer, 2002, Anti-SSA/Ro and anti-SSB/anti-La antibodies. What's new?, Ann Med Interne (París), 153, 520 Franceschini, 2005, Anti-Ro/SSA and anti-La/SSB antibodies, Autoimmunity, 38, 55, 10.1080/08916930400022954 Locht, 2005, Autoimmun Rev, 4, 276, 10.1016/j.autrev.2004.12.002 Ambrosi, 2012, Congenital heart block: evidence for a pathogenic role of maternal antibodies, Arthritis Res Ther, 14, 208, 10.1186/ar3787 Brito-Zerón, 2015, The clinical spectrum of autoimmune congenital heart block, Nat Rev Rheumatol, 11, 301, 10.1038/nrrheum.2015.29 Song, 2012, The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjögren's syndrome, Rheumatol Int, 32, 491, 10.1007/s00296-010-1790-x Hernández Molina, 2013, Predicting Sjögren syndromein patients with recent-onset SLE, Rheumatology (Oxf), 52, 1438, 10.1093/rheumatology/ket141 Peene, 2002, Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype, Ann Rheum Dis, 61, 1090, 10.1136/ard.61.12.1090 Peene, 2002, Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype, Ann Rheum Dis, 61, 1090, 10.1136/ard.61.12.1090 Pottel, 2004, Clinical optimization and multicenter validation of antigen-specific cut-off values on the INNO-LIA ANA update for the detection of autoantibodies in connective tissue disorders, Clin Exp Rheumatol, 22, 579 Eissfeller, 2005, Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases, Ann N Y Acad Sci, 1050, 327, 10.1196/annals.1313.035 López-Longo, 2003, Simultaneous identification of various antinuclear antibodies using an automated, Lupus, 12, 623, 10.1191/0961203303lu439oa Lyons, 2005, Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease, Ann N Y Acad Sci, 1050, 217, 10.1196/annals.1313.023 Hudson, 2012, Clinical significance of autoantibodies to R52/TRIM21 in systemic sclerosis, Arthritis Res Ther, 14, R50, 10.1186/ar3763 Ghillani, 2011, Clinical significance of anti-anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study, Autoimmun Rev, 10, 509, 10.1016/j.autrev.2011.03.004 Peene, 2002, Anti-anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease, Ann Rheum Dis, 61, 929, 10.1136/ard.61.10.929 Schulte-Pelkum, 2009, Latest update on the Ro/SS-A autoantibody system. Latest update on the Ro/SS-A autoantibody system, Autoimmun Rev, 8, 632, 10.1016/j.autrev.2009.02.010 Popovic, 2007, Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun, Lupus, 16, 10, 10.1177/0961203306073135 Retamozo, 2012, Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome, Clin Exp Rheumatol, 30, 686 Gál, 2000, Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome, Autoimmunity, 32, 89, 10.3109/08916930008994077 Meroni, 2010, ANA screening: an old test with new recommendations, Ann Rheum Dis, 69, 1420, 10.1136/ard.2009.127100 Brito-Zerón, 2014, Advances in the understanding and treatment of systemic complications in Sjögren's syndrome, Curr Opin Rheumatol, 26, 520, 10.1097/BOR.0000000000000096